1. A competitive protein-binding assay for 25-hydroxy vitamin D (25-OHD) in saliva has been established by adaptation of that previously described for 25-OHD in serum (Fairney et al. 1979) .
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Assay of 25-OHD in saliva General reagents. AnalaR (analytical grade) ethanol (EtOH) and methanol (MeOH), and standard laboratory grade dichloromethane (CH,Cl,) were freshly distilled before use. Sodium phosphate buffer (pH 7.5), barbitone buffer (pH 8.0), Triton XlOO and dextrancoated charcoal were prepared as previously described (Fairney et al. 1979) . Radioactivity was counted using RIA LUMA scintillant (LKB Instruments Ltd, South Croydon, Surrey).
Steroids. Unlabelled 25-OHD3 was supplied by Hoffmann-La Roche Inc., Nutley, N.J., 24(n) Extraction andassay procedure (see Table I ). Sonicated saliva (250 pl) was extracted with 5 ml CH,Cl,-MeOH (92 : 8 v/v) and estimations performed in duplicate as previously described (Fairney et al. 1979) with the following modifications. Tubes containing standard amounts of 12.5, 25, 50 and 100 pg) were prepared in 50 pl EtOH. Portions (1 -5 ml) of the CH,Cl,-MeOH sample extracts were used for assay and, after evaporation under nitrogen, 20 pl [3H]25-OHD, (8.7 pg) were added to each tube. Normal rat-kidney binding protein was used at 1 :4500 w/v in phosphate buffer.
Identijication of 25-0HD, in saliva
Unstimulated saliva (100 ml) was collected over a period of 2-3 h. This was divided into two portions in 500-ml round-bottomed, Quickfit flasks for lyophilization using an Edwards Modulyo freeze-drier (Edwards High Vacuum, Crawley, Sussex). After lyophilization, the residue was redissolved in 20 ml distilled water. This solution was then extracted three times each with 200 ml CH,CI,-MeOH (92 : 8, v/v), the extracts combined and the solvent evaporated under oxygen-free N, in a water-bath at 40".
This extract was then purified on a 100 x 10 mm column of Sephadex LH20 (Pharmacia (GB) Ltd, Hounslow, Middlesex), presoaked in hexane-chloroform-MeOH (9 : 1 : 1, by vol.). The column was calibrated with [3H]25-OHD3 and the extract from the 100 ml saliva was applied to the column and the 25-OHD, fractions collected. These were dried and further purified by high-pressure liquid chromatography using a reverse-phase Hypersil-ODS 250 mm column (Shandon Southern Products Ltd, Runcorn, Chesire), eluting with MeOH-water (92 : 8, v/v) at 1 ml/min. The 25-OHD3 fraction was collected, dried under N, and then rechromatographed on a straight-phase Hypersil250 mm column (Shandon), eluting with hexane-isopropyl alcohol (98 : 2,v/v). The 25-OHD3 fraction was collected and used for gas chromatography-mass spectrometry (GS-MS) analysis.
Initially derivatives of a standard sample of 25-OHD3 were prepared by treatment with hexamethyldisilazanetrimethyl chlorosilane -pyridine (2 : 1 : 3, by vol.) (Whitney et al. 1979 ) and analysed by GC-MS. The pyro and isopyro derivatives obtained were run on a 25 m glass capillary OV-1 column, fitted with a solid injection system, at 255", column temperature 240" programmed at 1 "/min. Mass spectroscopy was performed using a Varian MAT 731 mass spectrometer, source temperature 250", 8 kV accelerating voltage, 70 eV ionization potential and resolving power 1000. The spectra of the pyro form are shown in Fig. 1 and were obtained from approximately 80 ng 25-OHD3 injected. Under the conditions used, about 20 ng were necessary to obtain a readily recognizable, full spectrum. In addition, selected ion monitoring was also undertaken permitting detection of the compound at the 1 ng level.
Subsequently four portions of the salivary extract were treated with the trimethysilylation reagent as described previously. Each sample was examined by selected ion monitoring of ions m/z 454, 439, and 413. These were observed in the correct intensity ratios at the expected retention time. The remaining sample of the extract was then also trimethylsilylated and injected into the GC-MS and a spectrum of pyro-25-OHD3 TMS-2 obtained (Fig. 1) . Care was taken to avoid any 'wash-off' from the GC column from previously injected standard samples of 25-OHD3.
Measurement of free 25-OHD in serum Attempts to measure free 25-OHD by a dialysis method were unsuccessful as 25-OHD bound to the dialysis membranes used. An alternative ultracentrifugation method was therefore devised.
Serum (1-5 ml) was diluted with an equal volume of saline (9 g sodium chloride/l) in plastic ultracentrifugation tubes, 20 p1 EtOH containing [,H]25-OHD3 (0.04 pCi) added and the tubes mixed by inversion. The tubes were then incubated at 4" for 5 h followed by centrifugation in a Spinco model L ultracentrifuge (Beckman RIIC Ltd, High Wycombe, Bucks) using a SW5OL rotor head at 197000 g for 18 h at 4". Fractions (250 pl) were then carefully removed sequentially from the top of the tube and 25-OHD, vitamin D-binding protein and radioactivity measured. Vitamin D-binding protein was undetectable in the top four fractions and the percentage free 25-OHD was calculated (Beisel et al. 1964) .
Other assays
Measurements of 25-OHD in serum were performed as previously described (Fairney et al. 1979 ) and vitamin D-binding protein was measured by a commercially supplied radial immunodiffusion method for G, globulin (Hoechst Pharmaceuticals, Hounslow, Middlesex).
Subjects
Studies were undertaken on different groups of subjects to determine: (a) the random values of 25-OHD in saliva and their relation to the total amount of 25-OHD in serum (b) the relation of 25-OHD in saliva to free 25-OHD in serum, (c) whether or not the values of 25-OHD in saliva remained constant throughout the day or did they show any form of physiological variation.
Details of the subjects studied in each of the groups described are as follows: (a) random paired samples of saliva and serum were obtained from patients with miscellaneous diagnoses attending the department for phlebotomy; ( b ) as part of another study to assess the vitamin D status of 12-year-old local schoolchildren, there was sufficient spare serum from eighteen children to measure total 25-OHD, free 25-OHD by ultracentrifugation and vitamin D-binding protein of each sample. Specimens of saliva obtained at the time of phlebotomy were also available from subjects. A comparison of total 25-OHD in serum, free 25-OHD in serum, calculated free 25-OHD in serum using the total 25-OHD and vitamin D-binding-protein values (Bouillon et al. 1977) , and salivary 25-OHD values was therefore undertaken on these children; (c) the effect of dietary vitamin D on salivary 25-OHD values throughout the day was initially studied in two, male, normal volunteers. Serial saliva samples were collected throughout the day. Two daily salivary 25-OHD profiles were obtained in one of the volunteers: the 1st day when the subject took no food and only black coffee and the subsequent day when the usual diet containing 1.725 pg vitamin D was taken. The second volunteer provided samples throughout the day having taken lunch which included a vitamin D load (19.5 pg) taken in the form of pickled herrings (roll mops). Subsequently saliva was collected at different times throughout the day from three groups of 1 1-year-old male schoolchildren. The children were grouped according to race and diet so that the three groups studied were: Caucasian children on an English diet (group l), Asian children on an English diet (group 2) and Asian children on a vegetarian diet (group 3). The values obtained were log transformed before unbalanced analysis of variance. 
RESULTS
Assay of salivary 25-OHD
The standard curve is shown in Fig. 2 and the lower limit of sensitivity was 5 pg/tube. The intra-and interassay coefficients of variation are shown in Table 2 . Extraction recoveries were 100.6% (SD 2.8, n 63) and recoveries of unlabelled 25-OHD3 added to saliva samples of known 25-OHD content were 107.5 and 96.7% when 100 and 300 pg respectively were added to 1 ml saliva 30 min before assay. The values obtained on dilution of a single saliva sample are shown in Fig. 3 .
Identfication of 25-OHD3 in saliva
The presence of 25-OHD3 in saliva was detected by selected ion monitoring in all four portions of the salivary extract examined. The spectrum of pyro-25-OHD3 TMS-2 obtained after trimethylsilylation of the saliva extract is shown in Fig. l(b) . Although the spectrum is not as intense as would be desirable and contains a co-eluting contaminant, it firmly supports the presence of 25-OHD3 in saliva. The sample was estimated to contain about 20ng 25-OHD3. Therefore, as it was derived from 100ml saliva and the recovery of
[3H]25-OHD, using a similar preparatory procedure before GS-MS was 56 % , the concentration obtained in the sample examined was approximately 357 pg/ml or 954 pmol/l.
Random values of 25-OHD in saliva
The random values of salivary 25-OHD in patients attending for phlebotomy showed a very wide range (105-1000 pg/ml, n 55; see Fig. 4 ). The saliva results represented 1.2% of the serum results, and correlation analysis after log transformation of the values showed that there was a significant relation between the salivary and serum 25-OHD (r 0.45, P < 0-001 ; see Fig. 5 ).
Relations of salivary 25-OHD to free and serum 25-OHD The results of the comparison of total serum 25-OHD, free 25-OHD in serum, calculated free and salivary 25-OHD are shown in Fig. 6 . The measured free 25-OHD represented 0.66% of the total serum 25-OHD, the salivary 25-OHD represented 1.04% of the total serum 25-OHD and the calculated free 25-OHD 0.005% of the total amount in serum. After log transformation of the values, correlation analysis showed no relation between salivary 25-OHD and measured free 25-OHD in serum. However, there was a relation between salivary 25-OHD and the calculated amount of free 25-OHD in serum (r 0.5, P < 0.05).
Changes in salivary 25-OHD throughout the day
The studies of the two individual volunteers showed a flatter profile on the day that the first subject only drank black coffee compared with the following day when he took his normal diet (see Fig. 7 ). The second volunteer showed a marked evening rise in salivary 25-OHD, the peak response occurring 5-8 h after the load (see Fig. 8) .
The results of the salivary 25-OHD profiles in the three different groups of children are seen in Fig. 9 . Analysis of the individual groups showed that in both groups of children 
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eatingan English diet (groups 1 and 2) there was a significant variation with time throughout the day (P < 0.001). This was not seen in the group of Asian vegetarians (group 3) alone.
However, when all three groups (1-3) were analysed together there was a significant effect with time and type of child (P < 0.001).
DISCUSSION
In the present study we have found that 25-OHD is present in saliva, the values fluctuate throughout the day and quantitatively may be related to dietary vitamin D intake, and ethnic origin. At present the most widely used biochemical index of vitamin D status is the measurement of circulating 25-OHD (Avioli & Haddad, 1984) . The assays available measure the total protein-bound metabolite and have ignored the possible importance of free 25-OHD metabolites in blood. The determination of free vitamin D metabolites is important because it is still unclear whether the free or the total concentration of these metabolites is the physiologically important concentration. For example, values of 1,25-dihydroxy vitamin D and vitamin D-binding protein are increased during pregnancy (Bouillon et al. 1981 ) but pregnant women do not become hypercalcaemic. It is, therefore, unknown whether these changes are wholly related to the increase in binding protein due to pregnancy or represent a physiological homeostatic mechanism for maintaining normal calcium balance in the fetus. Consequently an accurate determination of free values of the vitamin D metabolites would be of great interest in this situation.
An attempt to overcome the lack of free metabolite measurements has been made by calculation of the free values from the total 25-OHD and vitamin D-binding protein results in serum (Bouillon et al. 1977) . These calculations used previously determined values of the binding-affinity constant of vitamin D-binding protein for the vitamin D metabolite of interest. Unfortunately, estimates of the binding-affinity constant of human vitamin D-binding protein for 25-OHD3 vary, so that considerable uncertainty about the validity of these calculations has arisen.
Direct measurement of the free fraction of the metabolite in blood has been difficult because of the very strong binding of 25-OHD to its transport protein, as well as technical problems. Estimation of the free fraction of other similar substances in plasma, e.g. testosterone, has been overcome by the estimation of the substance in saliva, and measurement of steroid hormones in saliva has been shown to reflect the unbound plasma concentration (Baxendale et al. 1982) . Salivary assays are non-invasive, and collection of samples is simple, providing an opportunity to look at variations of the substance measured throughout the day. The concentrations are very low, and therefore require specific and highly sensitive assays. Unconjugated steroids enter saliva by diffusing through the cells of the salivary glands and their concentration does not depend on the rate of saliva production. However, conjugated steroids enter saliva via ultrafiltration through the junction between the acinar cells and their concentration in saliva is highly flow-rate dependent (Vining et al. 1983) .
Our studies have shown it is relatively easy to measure 25-OHD in saliva by adjusting the concentration of binding protein and tracer to make a highly sensitive assay. The concentrations of 25-OHD that we found in saliva did not reflect the free values measured in serum, but the method for measuring the free fraction in blood was technically difficult to perform. An ultracentrifugation method had to be used as the more traditional dialysis method was unsuitable because 25-OHD3 adhered to the different dialysis membranes used. Using the results from the correlation of saliva and total serum values of 25-OHD, the percentage of 25-OHD in saliva was 1-04%, compared with 066% for the free metabolite measured, and 0.005% for the calculated free value. The percentage of metabolite present in saliva is similar to that obtained for testosterone (James, 1982) .
Our studies have confirmed the presence of 25-OHD3 in saliva by mass spectrometry using an extract of 100 ml saliva. The detection limit of the technique used is such that at least 200 pg/ml were present in the sample analysed even if calculations were not made for losses during preparation of the sample. This value is within the range of 105-1000 pg/ml for 25-OHD found in random samples of mixed saliva. The mass spectrometry value is likely to be lower than that obtained with mixed saliva using the simple 25-OHD competitive protein-binding assay, as this uses normal rat-kidney binding protein. This protein is known to cross-react with 25-OHD3, 25-hydroxy vitamin D,, 24,25-dihydroxy vitamin D, (Fairney et al. 1979) and possibly 25-OHD3 26,23-lactone. In addition, a diurnal fluctuation was found in our studies and as the sample analysed was collected in the late morning, and not when values were expected to be maximal in response to lunch, the result is within the part of the random range expected for the morning.
Studies on the presence of 25-OHD in human saliva by Trafford & Makin (1983) have, however, shown different results. Using a specific high-performance liquid chromatographic procedure in which they claim a lower limit of sensitivity of 50 pg/ml (130 pmol/l), no 25-OHD could be detected in saliva. Also using GC-MS a peak, possibly derived from 25-OHD3, was detected which was not in excess of 65 pmol/l(25 pg/ml). It is not obvious why these workers could not detect higher amounts of 25-OHD3 more comparable to our own findings. In the mass spectrometry part of Trafford & Makin's (1983) study the times of saliva collection are not specified so that it is possible that samples were obtained at times when the values would be expected to be very low in relation to the diurnal fluctuation. Also, Trafford & Makin (1983) used a different method of derivative preparation before mass spectrometry. Their method involved the formation of isotachysterol isomers which requires very carefully evaluated and controlled conditions to avoid destruction of the sample. It is possible that some of the 25-OHD3 in their sample was destroyed before analysis.
The wide variation of random values of salivary 25-OHD obviously prevents the use of this type of measurement as a replacement for random serum 25-OHD estimations. However, its variation throughout the day raises interesting questions. It is assumed that 25-OHD is present in an unconjugated form as for other steroid hormones. Therefore it should be relatively unaffected by salivary flow (Vining et al. 1983) . The effect of oral vitamin D loading to enhance the evening rise in salivary 25-OHD supports the view that the diurnal changes are related to diet. Examination of the profiles from the schoolchildren shows a small rise in salivary 25-OHD in the early afternoon in the Caucasian boys. It may be related to eating patterns throughout the day as the dietary questionnaires revealed that some of the children ate vitamin D in the form of fortified cereals for breakfast. Although seasonal variations in serum 25-OHD concentration are well established (McLaughlin et al. 1974) , diurnal variations of serum 25-OHD have not been observed (Juttmann et al. 1981) . The differences between seasonal and diurnal rhythms of serum 25-OHD may be explained by Fraser's (1981) The variation in salivary 25-OHD observed in the children studied may be related to the circadian rhythm that is now accepted as a basic element of human physiology (Moore-Ede et al. 1983) . The well-established circadian changes in cortisol secretion seem to anticipate an environmental change so that a peak is reached just before waking. The shape of the salivary 25-OHD profiles is, if anything, the reverse of this and more reminiscent of the growth hormone peak during the beginning of sleep. However, the highest salivary 25-OHD values occurred in the evening before sleep.
Vitamin D deficiency has been extensively documented in Asian subjects in Britain. Asian immigrants are known to have low plasma 25-OHD values (Preece et al. 1973) and to have a low dietary intake of vitamin D (Hodgkin et al. 1973) . The Asian vegetarian children that we studied had a lower dietary vitamin D intake than the Caucasian children. This may account for the lower salivary 25-OHD values in the Asian children.
The studies described in the present paper show the presence of 25-OHD in saliva and that it varies throughout the day. It most probably reflects the dietary intake of vitamin D and diurnal profiling of this metabolite might be very useful as the clinical test to assess the dietary source of this nutrient. In addition, the purpose of 25-OHD in saliva is interesting to speculate. In rats there are receptors for vitamin D in the parotid glands (Aoki et al. 1982; Peterfy & Tenenhouse 1982) and in the developing incisor teeth (Kim et al. 1983) . Microradiographs of rat incisor dentine show a regular alternation of highly and lowly mineralized bands. Dentinogenesis progresses at a rate of 20 pm/d (Simmons, 1981) . As a result circadian rhythms are seen as an important component of tooth growth in the rat. Diurnal variations of salivary vitamin D may have a physiological role in the mineralization process of the developing tooth. Further studies relating salivary 25-OHD profiles to age, sleep disorders, dietary deficiency of vitamin D and the morphology of teeth and bone are now required.
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